Tel: 732-484-9848
Fax: 888-484-5008
Email: sales@chemscene.com
   
Buliding blocks
Intermediates
Bioactive molecules
Product Pathways
All Targets
Anti-infection
Antibody-drug conjugate....
Apoptosis
Biochemical Reagent
Cell Cycle/DNA Damage
GPCR/G protein
Immunology/Inflammation
JAK/STAT Signaling
MAPK/ERK Pathway
Membrane Transporter/Io....
Metabolism/Protease
Neuronal Signaling
NF-KB
Others
PI3K/Akt/mTOR
Protein Tyrosine Kinase....
TGF-beta/Smad
Vitamin D Related
Wnt/Hedgehog/Notch
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Infection
Metabolic Disease
Neurological Disease
Others
Inflammation/Immunology
Product Type
All Products
New Products
Featured Products
Home   »   Product Pathways  »  Metabolic Disease  »  TAK-875

Products are for research use only. Not for human use. We do not sell to patients.


CS-0282 TAK-875


(TAK 875;TAK875)
Structure Price and Availability of    TAK-875
United States
Size Price Stock
5mg $140 In-stock Inquiry
10mg $246 In-stock
50mg $528 In-stock
100mg $855 In-stock
200 mg Get quote
500 mg Get quote
 Distributor In Japan:  フナコシ株式会社 www.funakoshi.co.jp    電話番号:81-3-5684-1620   
 FAX番号:81-3-5684-1775
Inquiry for price and availability only. Please place your order via our email or fax.
Contact us for competitive discounts on bulk quantities .
  • Data Sheet
  • Introduction
  • References
  • Related Products

TAK-875  M.Wt: 524.63
TAK-875  Formula: C29H32O7S
TAK-875  Solubility: DMSO ≥100mg/mL Water <1.2mg/mL Ethanol ≥10mg/mL
TAK-875  Purity: >98%
TAK-875  Storage:  Please store the product under the recommended conditions in the Certificate of Analysis.
CAS: 1000413-72-8

View current batch:

TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM. IC50 Value: 0.072 μM(EC50) Target: GPR40 in vitro: TAK-875 exhibits potent agonist activity and high binding affinity to the human GPR40 receptor with Ki of 38 nM. TAK-875 displays weaker affinity toward the rat GPR40 receptor with Ki of 140 nM. TAK-875 displays excellent selectivity, as TAK-875 has little agonist potency to other members of the FFA receptor family with EC50 of >10 μM. TAK-875 treatment induces a concentration-dependent increase in intracellular IP production in CHO-hGPR40 with EC50 of 72 nM, more potently than that of endogenous ligand agonist oleic acid which requires much higher ligand concentrations to activate the receptor with EC50 of 29.9 μM. Neither TAK-875 nor oleic acid elicits an IP response in control CHO cells devoid of hGPR40. in vivo: In type 2 diabetic N-STZ-1.5 rats, administration of TAK-875 (1-10 mg/kg p.o.) shows a clear improvement in glucose tolerance and augments insulin secretion. Additionally, TAK-875 (10 mg/kg, p.o.) significantly augments plasma insulin levels and reduces fasting hyperglycemia in male Zucker diabetic fatty rats, whereas in fasted normal Sprague-Dawley rats, TAK-875 neither enhances insulin secretion nor causes hypoglycemia even at 30 mg/kg.

GPR40  |  
Keywords: buy TAK-875 | TAK-875 Supplier | purchase TAK-875 | TAK-875 cost | TAK-875 manufacturer | order TAK-875 | TAK-875 distributor | TAK-875 structure,chemscene
buy 1000413-72-8 | 1000413-72-8 Supplier | purchase 1000413-72-8 | 1000413-72-8 cost | 1000413-72-8 manufacturer | order 1000413-72-8 | 1000413-72-8 distributor | 1000413-72-8 structure,chemscene


CHEMSCENE, LLC
Tel: 732-484-9848
Fax: 888-484-5008
Email:  sales@chemscene.com
Address: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852.
Products are for research use only. Not for human use. We do not sell to patients. Sitemap | Inhibitor © Copyright 2012. All Rights Reserved.